APC and neoplasm: The observation that vitamin D represses β-catenin signaling and that β-catenin activates the vitamin D receptor raise the possibility that impairment of the vitamin D pathway in vivo may affect the onset, incidence or progression of β-catenin-related neoplasias found in APC mutant mice [21].